Cosmos Health unit Cana signs 3-year deal to make 3.9 million VASCLOR GEST progesterone pessaries for Verisfield

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health unit Cana Laboratories signed a three-year contract manufacturing deal with Verisfield for VASCLOR GEST progesterone vaginal pessaries.
  • Production set at 1,300,000 units per year, totaling 3,900,000 units over the contract term.
  • Order expands Cana’s contract manufacturing into women’s health and diversifies its customer base.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606101532OMX_____CNEWS_EN_GNW9735066_en) on June 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.